Answers are grounded in this paper and cite their sources.
Combustible cigarettes, heated tobacco products (HTPs), and electronic nicotine delivery systems (ENDS) generate chemically different exposure profiles, yet they are frequently used concurrently. This critical review evaluates dual nicotine use as a mixed combustion-aerosol exposure scenario and focuses on the practical problem of biomarker attribution. Complete switching from cigarettes to non-combustible products can reduce several biomarkers of combustion-derived toxicants, whereas dual use often preserves cigarette-related exposure and may sustain nicotine intake. Nicotine metabolites quantify systemic dose but do not identify the delivery source. Exhaled carbon monoxide, carboxyhemoglobin, nicotelline, urinary 2-cyanoethyl mercapturic acid, and its longer-window hemoglobin adduct cyanoethylvaline provide complementary information about recent or sustained combustion. NNAL and minor tobacco alkaloids identify tobacco-derived exposure but do not establish combustion, while propylene glycol in urine, plasma, or saliva may support recent attribution to PG-containing ENDS. Metals and carbonyl-related markers have limited product specificity. Biomarkers of oxidative stress, inflammation, DNA damage, mitochondrial dysfunction, and endothelial injury indicate biological response rather than exposure source. We therefore propose a tiered attribution framework that interprets biomarkers along two axes: source specificity and temporal resolution. The framework combines product-use history with markers of nicotine intake, recent and longer-window combustion, tobacco substrate, recent vaping, device-associated constituents, and early biological effects. Cutoff-based verification panels are incorporated as a complementary compliance layer rather than as substitutes for source attribution. Dual use should not be treated as a uniform category or as evidence of harm reduction by default. Toxicological assessment should classify use patterns, document cigarette displacement, and distinguish reduced emissions, reduced internal exposure, and reduced disease risk.
No takes yet. Share an insight, caveat, or question.
Vukomanović et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: